Leishmaniasis is caused by parasitic protozoa of the genus Leishmania which, in the infected host are obliging intracellular parasite. Leishmania is a genus of trypanosomatid protozoa and reliable for Leishmaniasis. In this group Leishmania major is the etiological agent of cutaneous leishmaniasis that is prevalent in many tropical and subtropical areas of the world and transmits via the bite of an infected sand fly. The disease has a high incidence rate in Iran Alvar [ Alvar et al., 2010 ,Farmand et al., 2011 . The manifestation of disease is varying from self -limiting with life-long immunity to developing shape as chronic disease. When Leishmaniasis accompanied by deficient cellular immunity, the disease can improve to chronic shape[Von Stebut 2007 ,Douba et al., 2012 .The number of new cases of cutaneous leishmaniasis is estimated a range from 0.7 million to 1.2 million .The human immunodeficiency virus [HIV] and Leishmania co infection is reason of rapidly growing of Leishmaniasis in regions where Leishmania species are endemic. In the other hand toxicity of chemotherapy and currently available drugs for treatment haven't shown ideal consequence and ever important , resistance to current drugs , above all things underline to need for a safe, effective vaccine [Coler et al., 2005 ,Masina et al., 2003 .In recent years with completion of genome sequencing of L. major, researchers find out that some of genes are expressed in the infectious stages of the parasite and in particular, in amastigotes, which can help to design effective vaccines [ 
Cell preparation
Responses of specific and proliferation lymphocytes to Brdu technique was done . Spleen was removed from euthanized mice 3weeks after the last immunization and 3 weeks after the challenge infection. The tissues were macerated and washed in RPMI 1640 and incubated for five minutes in 0.17 M Tris pH 7.2 and 0.16 M NH4Cl to lyses erythrocytes. The splenocytes were washed and resuspended in RPMI 1640 supplemented with 20 mM sodium pyruvate, 5×10 5 M mercaptoethanol, 4 mM glutamine, 10%bovine fetal serum,100U/ml penicillin and 100µg/ml streptomycin. The cell's viability and number were assessed in an improved Newbauer chamber using 0.4% Trypan blue.
Cytokines assay before and after the challenge infection with L.major
The splenocyte cultures and cytokine assays were performed . Briefly, single-cell preparations from the spleen tissue were plated in duplicate in 24- 
Detection of antibody responses before and after the challenge infection with L. major
The blood samples were collected by retro-orbital puncture from the immunized mice 3 weeks after immunization and 3 weeks after challenge infection .The samples were centrifuged in 3000rpm for 15 min for serum preparation. The sera were tested for the presence of total anti-L. 
Determination of parasite burden
Three mice from each group were sacrificed seven weeks after challenge and parasite burden was determined as follows:A piece of spleen was excised, weighed and then homogenized with a tissue grinder in 2 ml of Schneider's Drosophila medium supplemented with 20%heat-inactivated fetal calf serum and Gentamicin [0.1%].Under sterile conditions ,the serial dilutions ranging from 1 to 1/4 x10 -4 were prepared in wells of 96 well micro titration plates. After 7 and 15 days of incubation at 26° C, the plates were examined with an inverted microscope at a magnification of 40x.The presence or absence of mobile promastigotes was recorded in each well. The final titer was the last dilution for which the well contained at least one parasite. The number of parasite per gram was calculated in the following way : Parasite burden=-log 10 To evaluate the proliferative responses of lymphocytes was used to Brdu test. The 3 weeks after three protein vaccination the proliferative responses of lymphocytes markedly were increased in the vaccinated groups, which were significantly higher than in control group. [P<0.05]. Before and after challenge infection in the vaccinated groups were no statistical significant difference but was statistical significant difference with control group [Fig. 1] .
We analyzed the levels of IFN-γ and IL-4 production in the supernatants of the spleen cells of all the 4 groups 3 weeks after immunization and 3 weeks after challenge infection with L.major. The 3 weeks after three protein vaccination IFN-γ 
DISCUSSION
Leishmania spp are responsible for a large variety of parasitic diseases in almost 90 countries. The disease is prevalent in many parts of the world, with about 12 million total cases worldwide. As many as 1.5-2 million new cases of cutaneous leishmaniasis and 500 000 cases of visceral leishmaniasis are reported every year [Handman 2001 ]. Immunity against re infection is acquired following cutaneous infection with Leishmania spp., suggesting that prophylactic immunization is feasible. A number of vaccine strategies have been tested, ranging from killed parasites to recombinant antigens or DNA or protein vaccines. No protective and effective anti-Leishmania vaccine is available at the moment in spite of several tested vaccine protocols Despite enormous effort of researchers to preparation of effective vaccine formula there is no protective vaccine and this failure turned to cell mediated immune system response in primarily impact to parasite [Handman 2001 ,Campos-Neto et al 2001 . In this level vaccine progresses strategy against L. major depends on proper and good defined antigen[s] and application of strong adjuvant in vaccine formulation to reach optimal immunity results.The availability of hundreds of adjuvants has prompted a need for identifying rational standards for the selection of adjuvant formulation based on immunological principles for human vaccines [Benhnini et al., 2009] . TSA family from humans to Saccharomyces cerevisiae has conserved domains and distinctive similarity in amino acid sequence has been seen in this group. S. cerevisiae thiol specific antioxidants confer safety against oxidative stress and damage. Mechanism of TSA action embedded in a thiol oxidation-based enzyme inhibition mode. Function of TSA protein depend on thioredoxin, thioredoxin reductase, and NADPH as reducing equivalents, then been define as thioredoxin peroxidase. thioredoxin as a reducing equivalent In S. cerevisiae help to reduction of H 2 O 2 molecules and participate in protection of mechanism against peroxidemediated oxidative damage Similar situation occurs inside macrophages. Respiratory burst in macrophages mediated by production of H 2 O 2 and TSA molecules as leishmania product, guarantee Leishmania survival inside the macrophages. Leishmania TSA protein is known as antigenic in both murine and human systems and is constitutive expressed in both promastigote and amastigote life stages [ Mendez et al., 2002 ,Chae et al., 1993 [Qiu et al 2008] . In this study our results showed that proliferative responses of lymphocytes and IFN-γ values before and after challenge infection in the vaccinated groups were no statistical significant difference but was statistical significant difference with control group but in IL-4 values Significant differences werenot observed between vaccinated and control groups .
In this study, we demonstrated that Montanide can effect on efficacy of a protein vaccine-encoding TSA against L. major infection and elicits cellular immune responses to the antigen delivered . The vaccine formulation described here may be an protection and excellent candidate for further vaccine development against Leishmania.
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